We have previously shown that chelated copper stimulates the release of luteinizing hormone-releasing hormone (LHRH) from isolated hypothalamic granules. In this study, we wished to ascertain if chelated copper acts on hypothalamic neurons to stimulate LHRH release and, if so, what is the ligand specificity of this interaction. An in vitro system of explants of the median eminence area (MEA) was established and characterized. MEA explants were exposed for 15 muin to 50 /uM copper, and then they were incubated for 75 min in copper-free medium. Copper led to a transient increase in the rate of LHRH release; the maximal rate was attained 15 min after transfer of the MEA to copper-free medium. In addition, we found that copper complexed to histidine (Cu-His), but not ionic copper, stimulated LHRH release, the magnitude of which was dependent on the dose of Cu-His. The chelator specificity for Cu complex action was such that Cu-His stimulated LHRH release 4.9-fold and Cu-Cys stimulated release 2.5-fold, whereas neither Cu-Thr, Cu-Gly-His-Lys, Cu-bovine serum albumin, nor ceruloplasmin stimulated LHRH release. Based on these results and those of others indicating that the concentration of copper in hypothalamic axonal terminals is 1-2 orders of magnitude greater than plasma, we propose that copper released in the vicinity of the LHRH neurons interacts with specific sites on the LHRH axonal terminals, which leads to release of the peptide.
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A small amount of cupric sulfate (50 ,g) leads to ovulation if it is administered into the posterior median eminence of the rabbit but not into other regions of the brain (1). Tsou et al. (2) observed increased levels of luteinizing hormone-releasing hormone (LHRH) in the pituitary stalk of the rabbit after the systemic administration of cupric acetate. We showed (3) (4) (5) that copper, at a concentration within the range required for the activity of several copper-dependent enzymes (6) (7) (8) (9) , markedly stimulates the release of LHRH from isolated hypothalamic granules. Based on these findings, we proposed (4) that copper plays a role in regulating LHRH release from LHRH neurons in the following manner. Newly taken up copper interacts with LHRH granules that are in close proximity to or in the process of fusing with the plasma membrane. Intraneuronal copper does not interact with LHRH granules, because it would be inactivated by reduced glutathione and copper-binding proteins (10, 11) .
It is well established that tissues obtain their copper supply from the circulation, where copper is chelated by proteins (ceruloplasmin, albumin), peptides, and amino acids. The current view is that the readily exchangeable pool of copper is that associated with albumin, small peptides, and amino acids (12, 13) . The following observations support the view that an active uptake mechanism for copper is operative in the hypothalamus. Copper is present in the hypothalamus in concentrations much greater than in blood (14, 15) , and in hypothalamic homogenates, copper is highly concentrated in synaptosomes (pinched-off axonal terminals) (16) . We noted (4, 5) 
MATERIALS AND METHODS
Animals. Male rats of the Long Evans strain (5-6 weeks old; 120-150 g) were used. Animals were killed by decapitation, and the median eminence area (MEA) was dissected and placed immediately in an incubation chamber containing ice-cold medium. The boundaries of the MEA extended from the posterior margin of the optic chiasm to the anterior margin of the mammillary bodies, -0.5 mm on both sides of the third ventricle and 0.5 mm in depth.
In Vitro Incubation. The incubation chamber was prepared according to Mendez et al.* by cutting a plastic disposable syringe (3 ml), using a hot scalpel, and immediately attaching the warm cut surface to a nylon mesh (pore size, 150 ,m) that sticks to the syringe. Each incubation chamber was immersed in a glass vial containing 0.6 ml of incubation medium (Krebs-Ringer phosphate buffer, pH 7,4, containing 0.01% leupeptin) and kept at 4°C for the duration of the collection of the MEA explants (2 MEA explants per chamber; 12-15 chambers per experiment). The incubation chambers were transferred to a Dubnoff metabolic shaker and tissues were incubated at 37°C under air with constant slow shaking (40-50 oscillations per min). While the tissue was incubating, another set of vials containing medium was placed in the water bath for warming. After 30 min, the incubation chamber containing the MEA was transferred to the warmed vial for further incubation. This warming-transfer procedure was then repeated every 15 min as many times as necessary. The glass vials containing the LHRH that has been released into the medium were covered with marbles and placed in a boiling water bath for 10 min, after which they were stored at -20°C until the assay (17) . At the end of the experiment, the MEA were recovered from the chamber and homogenized in Abbreviations: MEA, median eminence area; LHRH, luteinizing hormone-releasing hormone. *Mendez, U. M., Joseph-Bravo, P. & Charli, J. L., Congreso Nacional de Ciencias Fisiologicas, July 18, 1984 , Morelia, Mexico.
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incubation medium. Aliquots of the homogenate were taken for protein determination (18) and another aliquot was diluted and processed as described above for LHRH assay. Copper complexes (Cu/ligand molar ratio, 1:1) were prepared from the following stock solutions each diluted with incubation medium: 20 mM CuCl2 in water; 20 mM each His, Cys, Thr, or Gly-His-Lys in 0.1 M HCl; 100 ,uM bovine serum albumin in freshly prepared incubation medium. Ceruloplasmin was diluted to a final concentration of 50 A.M copper, according to the copper content specification of the ceruloplasmin obtained from Sigma. Synthetic LHRH was used to determine the recovery of LHRH released into the medium. LHRH Assay. LHRH was quantified by RIA according to Nett et al. (19) , using synthetic LHRH as the reference standard. The antiserum to LHRH (no. 5) was produced in our laboratory and its crossreactivity with other peptides and the characteristics of the assay have been described (20) . The lowest level of sensitivity of the assay was 1 pg per tube, and all values <1 were taken as 1 pg. Statistical analysis was carried out with one-way analysis of variance followed by the Student-Newman-Keuls test for multiple comparisons of means.
Source of Materials. Synthetic LHRH was from Beckman; L-histidine hydrochloride monohydrate, L-cysteine hydrochloride monohydrate, L-threonine, human ceruloplasmin type X, crystallized bovine serum albumin, and leupeptin were from Sigma; glycyl-L-histidyl-L-lysine acetate was from Aldrich; and CuC12 was from Baker. RESULTS
Characterization of the in Vitro Incubation System. MEA explants were incubated for 4.5 hr in incubation medium (basal release) and the release of LHRH was determined every 15 min. Basal release of LHRH was high in the first 30 min of incubation, but between 45 and 60 min, a steady low level of release was attained (Fig. 1) . When MEA explants were exposed to 50 p.M Cu-His for 15 min (between 60 and 75 min), the rate of LHRH release was increased at 15 min and was maximal by 30 min after the commencement of the exposure to Cu-His, the rates being 3.6-and 5.9-fold that of basal release, respectively. Between 30 and 90 min, the rate of LHRH release declined to a new steady level, which was 2-fold that of the basal (Fig. 1) lease is manifested 15 min later in the absence of Cu-His in the incubation medium.
The Ligand Specificity for Copper Complex Action. MEA explants were incubated for 15 min in the presence of either CuCI2, histidine, or Cu-His (50 ,M each), after which they were further incubated in medium alone for 75 min. We noted that Cu-His, but not CuCl2 or histidine, stimulated LHRH release (Fig. 4) , indicating that copper complex is the active form of copper. To test the ligand specificity of the copper complex, MEA explants were incubated for 15 min in the presence of either Cu-His, Cu-Cys, Cu-Thr, Cu-GlyHis-Lys, Cu-bovine serum albumin, or ceruloplasmin (50 AM copper each), after which the MEA explants were incubated for 15 min in copper-free medium, and LHRH release during this latter period was measured. Cu-His and Cu-Cys stimulated the rate of LHRH release 4.9-fold and 2.5-fold, respectively, whereas Cu-Thr, Cu-Gly-His-Lys, Cu-bovine serum albumin, or ceruloplasmin did not do so (Fig. 5) . In some experiments, we examined whether addition of histidine (50 ,M) to Cu-Gly-His-Lys, Cu-bovine serum albumin, or ceruloplasmin would facilitate copper action of these complexes and found that none of these complexes stimulated LHRH release.
DISCUSSION
The topographical distribution of LHRH neurons in the hypothalamus is such that within the median eminence LHRH is localized primarily in axonal terminals (21, 22) . Moreover, most of the hypothalamic content of the peptide (80%-90%) is concentrated in the median eminence (23, 24) . This topographical arrangement is ideal for the use of explants of this region as an in vitro model system to study the mechanisms underlying LHRH release and its regulation. The behavior and characteristics of the MEA explants in the in vitro system described in this study are similar to those described by others for MEA explants (25) (26) (27) : the explants are viable for several hours (4 hr in this study); they exhibit a low steady rate of release of the peptide; proteins are not detectable in the medium (indicating that the tissue is not deteriorating); the recovery of synthetic LHRH added to the medium is 84%-95% (indicating that peptidases are not leaking into the 4 . Effects of Cu-His, ionic copper, and histidine on LHRH release from MEA explants. MEA explants were incubated for 15 min in the presence of 50 uM Cu-His, CuC12, or histidine (S) and then for 75 min in incubation medium alone. Each value is mean + SEM; n = 9. medium); the tissue can respond to repeated stimulation; and the fractional amount of LHRH release in response to a specific stimulus is very small (=1.5% of the total tissue content). Using this in vitro system, we observed that copper stimulates a transient increase in the rate of LHRH release and that the maximal rate is attained 15 min after transfer of the MEA explant to a copper-free medium. These results are consistent with the existence of a readily releasable pool of LHRH in hypothalamic neurons and they support our earlier (Fig. 4) . [It should be emphasized that the stability constant for Cu-His complex is on the order of 109 L/mol and that even at an equimolar ratio, Cu2+ is complexed to histidine (28) .] Since in biological fluids and most importantly in blood, copper is present in a chelated form (12, 13, 29) and since histidine has been implicated in the transport of copper from blood to tissues (30, 31) 
